One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Strategies Potentially Associated With Increasing Racial and Ethnic Groups Underrepresented in Medicine
Michael Harrell Jr, MD1; Katherine Gergen Barnett, MD2; Susannah Rowe, MD, MPH1
doi : 10.1001/jamaophthalmol.2021.2124
JAMA Ophthalmol. 2021;139(8):825-826
Equity and the JAMA Network
Phil B. Fontanarosa, MD, MBA1; Annette Flanagin, RN, MA2; John Z. Ayanian, MD, MPP3,4; Robert O. Bonow, MD, MS5,6; Neil M. Bressler, MD7,8; Dimitri Christakis, MD, MPH9,10; Mary L. Disis, MD11,12; S. Andrew Josephson, MD13,14; Melina R. Kibbe, MD15,16; Dost ?ngür, MD, PhD17,18; Jay F. Piccirillo, MD19,20; Rita F. Redberg, MD, MPH21,22; Frederick P. Rivara, MD, MPH23,24; Kanade Shinkai, MD, PhD25,26; Clyde W. Yancy, MD, MSc27,28
doi : 10.1001/jamaophthalmol.2021.2403
JAMA Ophthalmol. 2021;139(8):827-829
Association of Allergic Conjunctivitis With Health-Related Quality of Life in Children and Their Parents
Shi-yao Zhang, MD1; Jing Li, MD1; Ren Liu, MD1; Hubert Yuenhei Lao, MD1; Zixin Fan, MD1; Ling Jin, MS1; Lingyi Liang, MD, PhD1; Yizhi Liu, MD, PhD1
doi : 10.1001/jamaophthalmol.2021.1708
JAMA Ophthalmol. 2021;139(8):830-837
Allergic conjunctivitis (AC) is one of the most common allergic diseases and is especially problematic in children and adolescents. The course of AC is generally prolonged and often recurs. Understanding the health-related quality of life (QOL) of both children with AC and their parents would be useful.
Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
James A. Proudfoot, MSc1; Linda M. Zangwill, PhD1; Sasan Moghimi, MD1; Christopher Bowd, PhD1; Luke J. Saunders, PhD1; Huiyuan Hou, MD, PhD1; Akram Belghith, PhD1; Felipe A. Medeiros, MD, PhD1,2; Eunice Williams-Steppe, MA1; Tess Acera, COA1; Keri Dirkes, MPH1; Robert Weinreb, MD1
doi : 10.1001/jamaophthalmol.2021.1812
JAMA Ophthalmol. 2021;139(8):839-846
Clinical trials of glaucoma therapies focused on protecting the optic nerve have required large sample sizes and lengthy follow-up to detect clinically relevant change due to its slow rate of progression. Whether shorter trials may be possible with more frequent testing and use of rate of change as the end point warrants further investigation.
Clinical Outcomes of Rhegmatogenous Retinal Detachment Treated With Pneumatic Retinopexy
Nicolas A. Yannuzzi, MD1; Charles Li, BA2; Danielle Fujino, MPH2; Scott P. Kelly, PhD2; Flora Lum, MD2; Harry W. Flynn Jr, MD1; D. Wilkin Parke III, MD3
doi : 10.1001/jamaophthalmol.2021.1860
JAMA Ophthalmol. 2021;139(8):848-853
Pneumatic retinopexy (PR) is the only clinic-based method of rhegmatogenous retinal detachment (RRD) repair. Registry-acquired clinical practice setting outcomes data with this procedure have not yet been reported.
New Classification for the Reporting of Complications in Retinal Detachment Surgical Trials
Zheng Yang Xu, MBBS1; Augusto Azuara-Blanco, MD1; Kazuaki Kadonosono, MD2; Timothy Murray, MD3; Sundaram Natarajan4; Samantha Sii, MBChB5; William Smiddy, MD6; David H. Steel, MD7; Thomas J. Wolfensberger, MD8; Noemi Lois, MD1; for the CORDS Study Group
doi : 10.1001/jamaophthalmol.2021.1078
JAMA Ophthalmol. 2021;139(8):857-864
Quantifying severity of complications in rhegmatogenous retinal detachment (RRD) surgical trials is needed. A consensus classification system will help surgeons to more effectively compare harms of different surgical techniques.
Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment
Eva K. Fenwick, PhD1,2; Semra Ozdemir, PhD2; Ryan E. K. Man, PhD1,2; Drishti Baid, BSc2; Hla M. Htoon, PhD1,2; Alfred T. L. Gan, MSc1; Min Li Tey, MBBS3; Ai T. Aw, MNR1; Mani Baskaran, PhD1; Monisha E. Nongpiur, PhD1; Eric A. Finkelstein, PhD2; Ching Siong Tey, BSc1,4; Hasita J. T. Soon, BSc1; Charumathi Sabanayagam, PhD1,2; Chelvin C. A. Sng, MRCS1,5; Tien Yin Wong, PhD1; Rahat Husain, MBBS1; Shamira A. Perera, MD1; Katherine Lun, MMED (Ophthalmology)5; Tin Aung, PhD1,2,3; Ecosse L. Lamoureux, PhD1,2
doi : 10.1001/jamaophthalmol.2021.1874
JAMA Ophthalmol. 2021;139(8):866-874
A glaucoma-specific instrument for estimating utilities across the spectrum of glaucoma severity is currently lacking, hindering the assessment of the cost-effectiveness of glaucoma treatments.
Refractive Outcomes After Immediate Sequential vs Delayed Sequential Bilateral Cataract Surgery
Julia P. Owen, PhD1; Marian Blazes, MD1; Megan Lacy, MS1; Ryan T. Yanagihara, MD1; Russell N. Van Gelder, MD, PhD1,2; Aaron Y. Lee, MD, MSCI1,2; Cecilia S. Lee, MD, MS1,2; for the IRIS Research Analytic Center Consortium
doi : 10.1001/jamaophthalmol.2021.2032
JAMA Ophthalmol. 2021;139(8):876-885
Approximately 2 million cataract operations are performed annually in the US, and patterns of cataract surgery delivery are changing to meet the increasing demand. Therefore, a comparative analysis of visual acuity outcomes after immediate sequential bilateral cataract surgery (ISBCS) vs delayed sequential bilateral cataract surgery (DSBCS) is important for informing future best practices.
Assessing the Uniformity of Uveitis Clinical Concepts and Associated ICD-10 Codes Across Health Care Systems Sharing the Same Electronic Health Records System
K. Matthew McKay, MD1; Nicholas Apostolopoulos, MD2; Mohammad Dahrouj, MD, PhD3; Huy V. Nguyen, MD4; Amit Reddy, MD5; Marian Blazes, MD1; Megan Lacy, MS1; Kathryn L. Pepple, MD, PhD1; Aaron Y. Lee, MD, MSCI1; Cecilia S. Lee, MD, MS1
doi : 10.1001/jamaophthalmol.2021.2045
JAMA Ophthalmol. 2021;139(8):887-894
Big data studies may allow for the aggregation of patients with rare diseases such as uveitis to answer important clinical questions. Standardization of uveitis-related variables will be necessary, including the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes used to identify patients of interest. There are currently limited data on the uniformity of diagnosis mapping to ICD-10 codes for uveitis diagnoses among different health systems.
Drawing Attention to the Burden of Allergic Conjunctivitis in Children and Their Families
Yi Ning J. Strube, MD, MS1,2
doi : 10.1001/jamaophthalmol.2021.1714
JAMA Ophthalmol. 2021;139(8):837-838
Planning Clinical Research and Clinical Care for Different Rates of Glaucoma Progression
Douglas R. Anderson, MD1; Elizabeth Anne Vanner, PhD2
doi : 10.1001/jamaophthalmol.2021.1821
JAMA Ophthalmol. 2021;139(8):846-847
Do We Really Need More Clinical Trials of Pneumatic Retinopexy?
David Yorston, MBChB1,2
doi : 10.1001/jamaophthalmol.2021.1850
JAMA Ophthalmol. 2021;139(8):853-854
When the N Is 65 Million—The Rise of Database Research
Christina Y. Weng, MD, MBA1; Judy E. Kim, MD2
doi : 10.1001/jamaophthalmol.2021.1853
JAMA Ophthalmol. 2021;139(8):855-856
What Is So Complicated About Defining Surgical Complications?
Ian C. Han, MD1; Elaine M. Binkley, MD1
doi : 10.1001/jamaophthalmol.2021.1091
JAMA Ophthalmol. 2021;139(8):864-865
Toward a Better Understanding of Value in Glaucoma Treatment
Joshua R. Ehrlich, MD, MPH1,2; Emily M. Schehlein, MD1
doi : 10.1001/jamaophthalmol.2021.1872
JAMA Ophthalmol. 2021;139(8):874-875
Immediate Sequential Bilateral Cataract Surgery—The Patient Perspective Should Prevail
Fasika A. Woreta, MD, MPH1; Oliver D. Schein, MD, MPH, MBA1
doi : 10.1001/jamaophthalmol.2021.2029
JAMA Ophthalmol. 2021;139(8):885-886
The Rigorous Work of Evaluating Consistency and Accuracy in Electronic Health Record Data
Karandeep Singh, MD1,2,3; Maria A. Woodward, MD, MSc3,4
doi : 10.1001/jamaophthalmol.2021.2042
JAMA Ophthalmol. 2021;139(8):894-895
Potential Impact of COVID-19 Disruptions on the Next Generation of Vision Scientists
James Jorkasky, MBA1; Miriam Davis, PhD2; Paul P. Lee, MD, JD3
doi : 10.1001/jamaophthalmol.2021.1959
JAMA Ophthalmol. 2021;139(8):896-897
Emerging vision scientists who have yet to be awarded their first independent funding may have their research careers disproportionately affected by early COVID-19–related disruptions. In September 2020, the Alliance for Eye and Vision Research convened a panel of 22 such scientists (nominated by their academic institutions) to communicate to the US Congress about the importance of vision research. As part of the effort, interviews were conducted with scientists about the effect of the pandemic on their research.
Reporting of Complications in Retinal Detachment Surgical Trials
Zheng Yang Xu, MBBS1; Augusto Azuara-Blanco, MD1; Kazuaki Kadonosono, MD2; Timothy Murray, MD3; Sundaram Natarajan, MD4; Samantha Sii, MBChB5; William Smiddy, MD3; David H. Steel, MD6,7; Thomas J. Wolfensberger, MD8; Noemi Lois, MD9; for the CORDS Study Group
doi : 10.1001/jamaophthalmol.2021.1836
JAMA Ophthalmol. 2021;139(8):898-905
Knowledge on the frequency and severity of complications in surgical trials for rhegmatogenous retinal detachment (RRD) is essential to determine whether surgical procedures are developed and compared adequately, taking into account not only efficacy but also harms.
Bilateral Macular Schisis in a Woman
Nita G. Valikodath, MD, MS1; Nicole K. Scripsema, MD1; Jennifer I. Lim, MD1,2
doi : 10.1001/jamaophthalmol.2020.5292
JAMA Ophthalmol. 2021;139(8):906-907
Purulent Conjunctivitis and Progressive Corneal Stromal Necrosis
Amer F. Alsoudi, BS1,2; Zeeshan Haq, MD2; Gerami D. Seitzman, MD2,3
doi : 10.1001/jamaophthalmol.2020.5442
JAMA Ophthalmol. 2021;139(8):908-909
Short Stature With Optic Atrophy and Cone Dystrophy
Yuri Seo, MD1; Sung Soo Kim, MD, PhD2; Jinu Han, MD3
doi : 10.1001/jamaophthalmol.2020.5777
JAMA Ophthalmol. 2021;139(8):910-911
Blurred Vision in a Young Woman With Cosmetic Iris Implants
Hasenin Al-khersan, MD1; Ann Q. Tran, MD2; Guillermo Amescua, MD1
doi : 10.1001/jamaophthalmol.2020.6549
JAMA Ophthalmol. 2021;139(8):912-913
Exudative Retinal Telangiectasia Associated With Leri-Weill Dyschondrosteosis
Rebecca Russ Soares, MD, MPH1; Maxwell S. Stem, MD2; Yoshihiro Yonekawa, MD1
doi : 10.1001/jamaophthalmol.2021.1856
JAMA Ophthalmol. 2021;139(8):914-915
Fundus Pigmentary Whorls in a Patient With Mosaicism for Tetrasomy 3q
Karen W. Jeng-Miller, MD, MPH1,2; Maan Alkharashi, MD3,4; Anne Fulton, MD3; Yoshihiro Yonekawa, MD5
doi : 10.1001/jamaophthalmol.2021.1954
JAMA Ophthalmol. 2021;139(8):915-917
Fundus Autofluorescence in Juxtapapillary Choroidal Hemangioma
Kuan-Jen Chen, MD1; Nan-Kai Wang, MD, PhD2; An-Ning Chao, MD1
doi : 10.1001/jamaophthalmol.2021.1948
JAMA Ophthalmol. 2021;139(8):e211948
Severe Bilateral Conjunctivitis With Corneal Limbal Infiltrates Associated With Dupilumab Treatment
Rachel Curtis, BScH, MD1; Jacob Rullo, MD, PhD1
doi : 10.1001/jamaophthalmol.2021.2012
JAMA Ophthalmol. 2021;139(8):e212012
Intraoperative Optical Coherence Tomography Guided Imaging of Incision-Site Descemet Membrane Dynamics During Phacoemulsification
Sridevi Nair, MD1; Manpreet Kaur, MD1; Jeewan Singh Titiyal, MD1
doi : 10.1001/jamaophthalmol.2021.2104
JAMA Ophthalmol. 2021;139(8):917-918
Intraoperative Optical Coherence Tomography Guided Imaging of Incision-Site Descemet Membrane Dynamics During Phacoemulsification—Reply
Ye Dai, MD, PhD1; Lixia Luo, MD, PhD1; Yizhi Liu, MD, PhD1
doi : 10.1001/jamaophthalmol.2021.2107
JAMA Ophthalmol. 2021;139(8):918
Methodological Considerations for the Case-Control Study of Metformin and Age-Related Macular Degeneration
Mahyar Etminan, PharmD, MSc(Epi)1; Mohit Sodhi, MSc1,2; Lingyi Li, MSc2
doi : 10.1001/jamaophthalmol.2021.2129
JAMA Ophthalmol. 2021;139(8):918-919
Methodological Considerations for the Case-Control Study of Metformin and Age-Related Macular Degeneration—Reply
Andrea L. Blitzer, MD1; Sandra A. Ham, MS2; Dimitra Skondra, MD, PhD1
doi : 10.1001/jamaophthalmol.2021.2132
JAMA Ophthalmol. 2021;139(8):919-920
Additional Considerations Regarding Timolol Eyedrops for Acute Treatment of Migraine
Anand S. Brar, MBBS, MD1; Manmeet K. Brar, MBBS2
doi : 10.1001/jamaophthalmol.2021.1783
JAMA Ophthalmol. 2021;139(8):920
Additional Considerations Regarding Timolol Eyedrops for Acute Treatment of Migraine—Reply
Abraham Kurian, MS, DO1; Iodine Reghunadhan, DNB1; Unnikrishnan Nair, MS1
doi : 10.1001/jamaophthalmol.2021.1786
JAMA Ophthalmol. 2021;139(8):920-921
Retinal Microvascular and Choroidal Changes in Parkinson Disease
Jeeyun Ahn, MD, PhD1; Joo Young Shin, MD, PhD1; Jee-Young Lee, MD, PhD2
doi : 10.1001/jamaophthalmol.2021.1728
JAMA Ophthalmol. 2021;139(8):921-922
Retinal Microvascular and Choroidal Changes in Parkinson Disease—Reply
Cason B. Robbins, BS1; Dilraj S. Grewal, MD1; Sharon Fekrat, MD1
doi : 10.1001/jamaophthalmol.2021.1731
JAMA Ophthalmol. 2021;139(8):922
Risk of SARS-CoV-2 Transmission via Corneal Transplant From Donors With COVID-19
Kelvin H. Wan, MBChB1; Vanissa W.S. Chow, MBBS2; Dennis S.C. Lam, MD3
doi : 10.1001/jamaophthalmol.2021.2148
JAMA Ophthalmol. 2021;139(8):922-923
Risk of SARS-CoV-2 Transmission via Corneal Transplant From Donors With COVID-19—Reply
Maria Casagrande, MD1; Martin S. Spitzer, MD1; Maximilian Schultheiss, MD1
doi : 10.1001/jamaophthalmol.2021.2151
JAMA Ophthalmol. 2021;139(8):923-924
Error in Group Author Listing
doi : 10.1001/jamaophthalmol.2021.2697
JAMA Ophthalmol. 2021;139(8):924
Error in Group Author Listing
doi : 10.1001/jamaophthalmol.2021.2725
JAMA Ophthalmol. 2021;139(8):924
